Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients
Current Oncology · 02.11.2023 · 30 (11) · 9701-9709
DOI: 10.3390/curroncol30110704 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 02.11.2023. Verfasst von Genevieve Chaput und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Supportive and Palliative Care, McGill University Health Centre, Department of Family Medicine, McGill University, Montreal, QC H4A 3J1, …. Hauptthemen laut MEDLINE: Deprescriptions, Drug-Related Side Effects and Adverse Reactions, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Patients with incurable cancers have an increasing number of comorbidities, which can lead to polypharmacy and its associated adverse events (drug-to-drug interaction, prescription of a potentially inappropriate medication, adverse drug event). Deprescribing is a patient-centered process aimed at optimizing patient outcomes by discontinuing medication(s) deemed no longer necessary or potentially inappropriate. Improved patient quality of life, risk reduction of side effects or worse clinical outcomes, and a decrease in healthcare costs are well-documented benefits of deprescribing. Deprescribing and advance care planning both require consideration of patients’ values, preferences, and care goals. Here, we provide an overview of comorbidities and associated polypharmacy risks in cancer patients, as well as useful tools and resources for deprescribing in daily practice, and we shed light on how deprescribing can facilitate advance care planning discussions with patients who have advanced cancer or a limited life expectancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Supportive and Palliative Care, McGill University Health Centre, Department of Family Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Zitieren
APA
Chaput, G., & Bhanabhai, H. (2023). Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients. Current Oncology, 30(11), 9701-9709. https://doi.org/10.3390/curroncol30110704
Vancouver
Chaput G, Bhanabhai H. Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients. Current Oncology. 2023;30(11):9701-9709. doi:10.3390/curroncol30110704
BibTeX
@article{Chaput2023,
author = {Chaput, Genevieve and Bhanabhai, Hitesh},
title = {Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {11},
pages = {9701--9709},
doi = {10.3390/curroncol30110704}
}
EUVIMED